My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Gilead Sciences (NQ:GILD)

126.25 -0.93 (-0.73%)

Streaming Delayed Price Updated: 12:16 PM EST, Nov 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

68 69 Next >

Gilead to Highlight Landmark Progress in Research Across HIV Prevention, Treatment and Cure Programs at AIDS 2024

July 16, 2024

From Gilead Sciences, Inc.

Via Business Wire

The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024 ↗

July 15, 2024

Undervalued Nasdaq 100 stocks may not be as rare as hen's teeth but not quite so plentiful amid a raging bull market.

Via InvestorPlace

Positive News is Driving This Cancer Drug Maker’s Stock Higher

July 15, 2024

IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather

Via MarketBeat

3 Dividend Growth Stocks to Buy and Hold ↗

July 14, 2024

What's better than a dividend? A dividend that's growing.

Via The Motley Fool

Gilead Sciences's Options Frenzy: What You Need to Know ↗

July 11, 2024

Via Benzinga

Looking Into Gilead Sciences's Recent Short Interest ↗

July 10, 2024

Via Benzinga

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $8,400 Today ↗

July 09, 2024

Via Benzinga

Is Iovance Biotherapeutics a Millionaire Maker? ↗

July 14, 2024

This biotech's future is bright, but how good could it get for investors?

Via The Motley Fool

The 7 Most Undervalued Healthcare Stocks to Buy in July 2024 ↗

July 13, 2024

Explore undervalued healthcare stocks offering growth potential and stability in contrast to overvalued tech sector.

Via InvestorPlace

3 Underappreciated Stocks About to Break Their Chains ↗

July 11, 2024

Explore these underappreciated stocks ready for growth and get an in-depth analysis, forecasts, and news on these potential breakout stocks.

Via InvestorPlace

Oil Declines Amid Prospects Of An Agreement Between Israel And Hamas. Powell Will Address The Us Congress Today ↗

July 09, 2024

On Monday, the Dow Jones (US30) decreased by 0.08%, while the S&P 500 (US500) added 0.10%. The NASDAQ Technology Index (US100) closed positive 0.28%.

Via Talk Markets

Topics Stocks

7 Cheap Biotech Stocks With Major Upside Potential ↗

July 09, 2024

While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.

Via InvestorPlace

Key Takeaways From Gilead Sciences Analyst Ratings ↗

July 01, 2024

Via Benzinga

Gilead Sciences's Options Frenzy: What You Need to Know ↗

June 24, 2024

Via Benzinga

Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗

July 08, 2024

Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.

Via Talk Markets

This Domino's Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

July 08, 2024

Via Benzinga

Amgen, Inc. Dividend Stock Analysis ↗

July 05, 2024

Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.

Via Talk Markets

FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals ↗

July 04, 2024

Biotech stocks are on the verge of a comeback after a period of underperformance amid a wave of FDA approvals.

Via InvestorPlace

3 Undervalued Biotech Gems With 200%+ Analyst Price Targets ↗

July 04, 2024

These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise.

Via InvestorPlace

3 Magnificent Stocks Retirees Can Buy and Hold Forever ↗

July 01, 2024

These stocks could be ideal for investors in their golden years.

Via The Motley Fool

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields ↗

June 28, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

June 25, 2024

Via Benzinga

7 Dividend Stocks to Buy Now: June 2024 ↗

June 23, 2024

These dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.

Via InvestorPlace

DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio? ↗

June 23, 2024

Top performers last week were SRPT (+29.50%), SIRI (+16.73%), TOST (+15.57%), GILD (+12.62%), CHWY (+10.59%), ACN (+9.80%), DKNG (+9.69%), DELL (+8.19%), ADSK (+7.99%), and GFI (+7.15%).

Via Benzinga

MarketBeat Week in Review – 6/17 - 6/21

June 22, 2024

Markets were calmer this week, with the Dow index posting the biggest gains, but it's too early to tell if this is the start of a broader market rally

Via MarketBeat

Topics Economy Stocks

Top Analyst Reports For Abbott, BP & Gilead ↗

June 21, 2024

Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories, BP p.l.c.and Gilead Sciences, Inc., as well as two micro-cap stocks Smith-Midland Corp. and...

Via Talk Markets

Nvidia Snaps 8-Week Winning Run, S&P 500 Marks Longest Streak Without A 2% Drop Since Great Recession, Oil Prices Stage Comeback: This Week In The Market ↗

June 21, 2024

Stock market rally continues with new highs in S&P 500 and Nasdaq 100, driven by tech and semiconductor sectors, but concerns arise over lack of broad participation and high concentration in mega-cap...

Via Benzinga

Topics Economy Stocks

Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments ↗

June 21, 2024

Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.

Via Benzinga

Why Gilead Sciences Stock Is Trading Higher Friday ↗

June 21, 2024

On Thursday before the market opened, Gilead announced efficacy data for its possible HIV prevention drug, Lenacapavir.

Via Benzinga

Pre-Market Movers - June 21, 2024 ↗

June 21, 2024

Sarepta jumps after announcing expanded approval of DMD drug and more news on today's top movers.

Via Talk Markets

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.